These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL. van den Akker JM; Bredie SJ; Diepenveen SH; van Tits LJ; Stalenhoef AF; van Leusen R J Nephrol; 2003; 16(2):238-44. PubMed ID: 12768071 [TBL] [Abstract][Full Text] [Related]
49. Myomas and reproductive function. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2004 Sep; 82 Suppl 1():S111-6. PubMed ID: 15363705 [No Abstract] [Full Text] [Related]
50. The effect of oral contraceptives on total-body potassium. Flynn MA; Coffman W; Hall D Arch Environ Health; 1968 Dec; 17(6):848-9. PubMed ID: 5699292 [No Abstract] [Full Text] [Related]
53. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related]
54. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
55. Physiologic and pharmacologic effects of estrogen and progestins on bone. DeCherney A J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857 [TBL] [Abstract][Full Text] [Related]
56. [Changes of the ovarian and uterine blood vessels following administration of progestational substances]. ten Berge BS Arch Gynakol; 1969; 207(1):52-3. PubMed ID: 5819980 [No Abstract] [Full Text] [Related]
57. [The use of oral ovulation-inhibitor hormones. Preliminary report]. Bergher de Bacalao E; Merchán López D Rev Obstet Ginecol Venez; 1966; 26(3):541-50. PubMed ID: 5986948 [No Abstract] [Full Text] [Related]
58. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A. Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595 [TBL] [Abstract][Full Text] [Related]
59. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives]. Boyet F Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510 [TBL] [Abstract][Full Text] [Related]